Attention Deficit and Disruptive Behavior Disorders 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Attention Deficit and Disruptive Behavior Disorders
NCT01233856: Omega-3 Fatty Acids as an Adjunctive Therapy for Treatment in Attention-Deficit Hyperactivity Disorder (ADHD)

Recruiting
N/A
30
US
Lovaza, Placebo (corn oil).
Maimonides Medical Center, GlaxoSmithKline
Attention-Deficit/Hyperactivity Disorder
06/12
06/12

Download Options